Plasma filtration

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 10, 2005, Pages 615-624

  Tan, Han Khim ^a   Hart, G ^b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

Immunotherapy; Plasma exchange; Plasma membrane

Indexed keywords

BLOOD; BLOOD FILTRATION; CELL MEMBRANE; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOCRINE DISEASE; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; HUMORAL IMMUNITY; KIDNEY DISEASE; NEUROLOGIC DISEASE; PLASMA; PLASMAPHERESIS; REVIEW;

EID: 33644597597     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Prince JE, Kheradmand F, Corry DB. Immunologic lung disease. J Allergy Clin Immunol 2003;111:613-23.
2. Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002;59(Suppl):S7-S12.
3. Brasington RD Jr, Kahl LE, Ranganathan P, Latinis KM, Velazquez C, Atkinson JP. Immunologic rheumatic disorders. J Allergy Clin Immunol 2003;111(Suppl):S593-S601.
4. Nambiar MP, Mitchell JP, Ceruti RP, Malloy MA, Tsokos GC. Prevalence of T cell receptor zeta chain deficiency in systemic lupus erythematosus. Lupus 2003;12:46-51.
5. Creange A, Gregson NA, Hughes RA. Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcgammaRII expression in patients with chronic inflammatory neuropathies. J Neuroimmunol 2003;135:91-5.
6. Kwa MS, van Schaik IN, De Jonge RR, Brand A, Kalaydjieva L, van Belzen N, et al. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. Brain 2003;126:361-75.
7. Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, et al. Lowering anti-dsDNA antibodies - what's new? Lupus 2002;11:885-94.
8. Cannella B, Raine CS. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2004;55:46-57.
9. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999;27:2096-104.
10. Kanda T, Yamawaki M, Mizusawa H. Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model. Neurology 2003;60:301-6.
11. Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, Tonutti E, et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 2003;12:31-6.
12. Silvestris F, Grinello D, Tucci M, Cafforio P, Dammacco F. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus. Lupus 2003;12:8-14.
13. Alvarez-Larran A, Petriz J, Martinez A, Sanz C, Pereira A. Plasma from patients with thrombotic thrombocytopaenic purpura induces activation of human monocytes and polymorphonuclear neutrophils. Br J Haematol 2003;120:129-34.
14. Dominguez JH, Sha E. Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases. Ther Apher 2002;6:69-76.
15. Weide R, Heymanns J, Pandorf A, Koppler H. Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 2003;12:779-82.
16. Abraham KA, Brown C, Conlon PJ, Donohoe J, Hickey DP, O'Neill D, et al. Plasmapheresis as rescue therapy in accelerated acute humoral rejection. J Clin Apheresis 2003;18:103-10.
17. Ioannou Y, Isenberg DA. Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J 2002;78:599-606.
18. van Schaik IN, Winer JB, de Haan R, Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systemic review. Lancet Neurol 2002;1:491-8.
19. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs late. Intensive Care Med 1999;25:805-13.
20. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective, randomised trial. Lancet 2000;356:26-30.
21. Norda R, Stegmayr BG; Swedish Apheresis Group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apheresis Sci 2003;29:159-66.
22. Korach JM, Petitpas D, Paris B, Bourgeade F, Passerat V, Berger P, et al; French Registry Study Group. Plasma exchange in France: Epidemiology 2001. Transfus Apheresis Sci 2003;29:153-7.
23. Winters JL, Pineda AA. New directions in plasma exchange. Curr Opin Hematol 2003;10:424-8.
24. Kieseier BC, Hartung HP. Therapeutic strategies in the Guillain-Barré syndrome. Semin Nephrol 2003;23:159-68.
25. Hughes RA. Management of chronic inflammatory demyelinating polyradiculoneuropathy. Drugs 2003;63:275-87.
26. Gogovska L, Ljapcev R, Polenakovic M, Stojkovski L, Popovska M, Grcevska L. Plasma exchange in the treatment of myasthenia gravis associated with thymoma. Int J Artif Organs 2003;26:170-3.
27. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J 2003;79:11-7.
28. Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, et al. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 2003;82:27-38.
29. Hellstern P, Muntean W, Schramm W, Seifried E, Solheim B. Practical guidelines for the clinical use of plasma. Thromb Res 2002;107:S53-S57.
30. Karthikeyan V, Parasuraman R, Shah V, Vera E, Venkat KK. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant 2003;3:1289-94.
31. Yarranton H, Machin SJ. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura. Curr Opin Neurol 2003;16:367-73.
32. Dervenoulas J, Tsirigotis P, Bollas G, Koumarianou AA, Pappa V, Mantzios G, et al. Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases. Acta Haematol 2001;105:204-8.
33. Yang CW, Chen YC, Dunn P, Chang MY, Fang JT, Huang CC. Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases. Ren Fail 2003;25:21-30.
34. Zarkovic M, Kwaan HC. Correction of hyperviscosity by apheresis. Semin Thromb Hemost 2003;29:535-42.
35. Yeh JH, Lee MF, Chiu HC. Plasmapheresis for severe lipemia: comparison of serum lipid clearance rates for the plasma exchange and double-filtration variants. J Clin Apheresis 2003;18:32-6.
36. Klingel R, Fassbender T, Fassbender C, Gohlen B. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis. Therap Apher Dial 2003;7:350-8.
37. Straube R, Gackler D, Thiele A, Muselmann L, Kingreen H, Klingel R. Membrane differential filtration is safe and effective for the long-term treatment of Refsum's syndrome-an update of treatment modalities and pathophysiological cognition. Transfus Apheresis Sci 2003;29:85-91.
38. Zabaleta-Lanz M, Vargas-Arenas RE, Tapanes F, Daboin I, Atahualpa Pinto J, Bianco NE. Silent nephritis in systemic lupus erythematosus. Lupus 2003;12:26-30.
39. Kaplan AA. The use of apheresis in immune renal disorders. Therap Apher Dial 2003;7:165-72.
40. Kaplan AA. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis. Ther Apher 1997;1:255-9.
41. Shehata N, Kouroukis C, Kelton JG. A review of randomized controlled trials using therapeutic apheresis. Transfus Med Rev 2002;16:200-29.
42. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003;42:1149-53.
43. Schneider KM. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy. Kidney Int 1998;53(Suppl):S61-S65.
44. Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003;31:1730-6.
45. Stegmayr BG, Jakobson S, Rydvall A, Bjorsell-Ostling E. Plasma exchange in patients with acute renal failure in the course of multiorgan failure. Int J Artif Organs 1995;18:45-52.
46. Reeves JH. A review of plasma exchange in sepsis. Blood Purif 2002;20:282-8.
47. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002;28:1434-9.
48. Unger JK, Haltern C, Dohmen B, Rossaint R. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions. J Clin Apheresis 2002;17:190-8.
49. Hirata N, Shizume Y, Shirokaze J, Suemitsu J, Yoshida H, Yamawaki N. Plasma separator Plasmaflo OP. Ther Apher Dial 2003;7:64-8.
50. Rogiers P, Zhang H, Pauwels D, Vincent JL. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med 2003;31:1219-25.
51. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder Re, De Sutter J, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-53.
52. Kaplan AA. General principles of therapeutic plasma exchange. Semin Dial 1995;8:294-8.
53. Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans 1990;36:M597-M599.
54. Haltern C, Unger JK, Dohmen B, Gressner AM, Rossaint R. The influence of HES on the filtration properties of capillary membrane Plasmaseparation. Int J Artif Organs 2002;25:798-805.
55. Pohl MA, Lan SP, Berl T; the Lupus Nephritis Collaborative Study Group. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 1991;114:924-9.
56. Tetta C, Cavaillon JM, Camussi G, Lonnemann FG, Brendolan A, Ronco C. Continuous plasma filtration coupled with sorbents. Kidney Int 1998;53(Suppl):S186-S189.
57. Ronco C, Brendolan A, d'Intini V, Ricci Z, Wratten ML, Bellomo R. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif 2003;21:409-16.
58. Felix SB, Staudt A, Friedrich GB. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Autoimmunity 2001;34:211-5.